About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Psychiatry, Mental Health and Addictions Research Group at the Vall d'Hebron Research Institute is a multidisciplinary team that over the past 13 years has focused its scientific activity on the research (both nationally and internationally) of clinical, therapeutic and etiopathogenic aspects of:
At international level, it participates and/or coordinates several European projects of great repercussion in the area of mental health. At national level, it is part of the CIBERSAM (Centre for Biomedical Research in Mental Health Network) together with other leading groups, conducting research of excellence.
PMID: 35151951 Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY Year: 2022 Reference: Eur Neuropsychopharmacol. 2022 Apr;57:69-74. doi: 10.1016/j.euroneuro.2022.01.110. Epub 2022 Feb 11. Impact factor: 4.6 Publication type: Paper in international publication Authors: Muntaner-Mas, Adria; Reinhard, Iris; Reichert, Markus; Giurgiu, Marco; Ebner-Priemer, Ulrich W; Ortega, Francisco B; Bergsma, Douwe; Pawley, Adam D; Koch, Elena D; Freitag, Christine M et al. DOI: 10.1016/j.euroneuro.2022.01.110
PMID: 35732390 Journal: BMJ Open Year: 2022 Reference: BMJ Open. 2022 Jun 22;12(6):e060822. doi: 10.1136/bmjopen-2022-060822. Impact factor: 2.692 Publication type: Paper in international publication Authors: Lusilla-Palacios, Pilar; Ramos-Quiroga, Jose Antonio; Vazquez-De Sebastian, Julia; Puig, Gemma Parramon; Ciudin, Andreea; Comas, Marta; Cano Porras, Desiderio; Spanlang, Bernhard; Slater, Mel; Anastasiadou, Dimitra et al. DOI: 10.1136/bmjopen-2022-060822
PMID: 34796836 Journal: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Year: 2022 Reference: Clin Exp Rheumatol. 2022 Jun;40(6):1102-1111. doi: 10.55563/clinexprheumatol/uzzejn. Epub 2021 Nov 18. Impact factor: 4.473 Publication type: Paper in international publication Authors: Maurel, Sara; Saez-Francas, Naia; Calvo, Natalia; Alegre-Martin, Jose; Castro-Marrero, Jesus et al. DOI:
PMID: 35792729 Journal: INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PR Year: 2022 Reference: Int J Psychiatry Clin Pract. 2022 Jul 6:1-10. doi: 10.1080/13651501.2022.2064308. Impact factor: 1.812 Publication type: Review in international publication Authors: Sanchez-Lafuente, Carlos Gomez; Gomez-Revuelta, Marcos; Arques-Egea, Sergio; Almenta Gallego, David; Fraguas, David; Hernandez Huerta, Daniel; Nunez Arias, Daniel; Parro Torres, Carlos; Alamo, Cecilio; Ros Cucurul, Elena et al. DOI: 10.1080/13651501.2022.2064308
PMID: 33495439 Journal: Nature Communications Year: 2021 Reference: Nat Commun. 2021 Jan 25;12(1):576. doi: 10.1038/s41467-020-20443-2. Impact factor: Publication type: Paper in international publication Authors: Als, Thomas D; Andreassen, Ole A; Arranz, Maria Jesus; Artigas, Maria Soler; Baekvad-Hansen, Maria; Banaschewski, Tobias; Bau, Claiton; Bellgrove, Mark; Biederman, Joseph; Borglum, Anders D et al. DOI: 10.1038/s41467-020-20443-2
PMID: 33495110 Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY Year: 2021 Reference: Eur Neuropsychopharmacol. 2021 Mar;44:1-13. doi: 10.1016/j.euroneuro.2021.01.002. Epub 2021 Jan 23. Impact factor: Publication type: Review in international publication Authors: Pujol-Gualdo, Natalia; Ramos-Quiroga, Josep Antoni; Ribases, Marta; Sanchez-Mora, Cristina; Soler Artigas, Maria et al. DOI: 10.1016/j.euroneuro.2021.01.002
PMID: 33456050 Journal: MOLECULAR PSYCHIATRY Year: 2021 Reference: Mol Psychiatry. 2021 Jun;26(6):2101-2110. doi: 10.1038/s41380-020-01002-z. Epub 2021 Jan 17. Impact factor: Publication type: Paper in international publication Authors: Andreassen, Ole; Buitelaar, Jan K; Ching, Christopher R K; Faraone, Stephen V; Franke, Barbara; Hess, Jonathan L; Hoogman, Martine; Jahanshad, Neda; McDonald, Carrie; Radonjic, Nevena V et al. DOI: 10.1038/s41380-020-01002-z
PMID: 33038681 Journal: ADDICTIVE BEHAVIORS Year: 2021 Reference: Addict Behav. 2021 Feb;113:106681. doi: 10.1016/j.addbeh.2020.106681. Epub 2020 Oct 1. Impact factor: Publication type: Paper in international publication Authors: Daigre, Constanza; Grau-Lopez, Lara; Martinez-Luna, Nieves; Palma-Alvarez, Raul Felipe; Palma-Alvarez, Raul Felipe; Perea-Ortueta, Marta; Ramos-Quiroga, Josep Antoni; Roncero, Carlos; Ros-Cucurull, Elena; Serrano-Perez, Pedro et al. DOI: 10.1016/j.addbeh.2020.106681
PMID: 30849401 Journal: NEUROPHARMACOLOGY Year: 2019 Reference: Neuropharmacology. 2019 Sep 15;156:107557. doi: 10.1016/j.neuropharm.2019.02.039. Epub 2019 Mar 6. Impact factor: 4.367 Publication type: Editorail in international publication Authors: Mortimer, Niall, Ganster, Tatjana, O'Leary, Aet, Popp, Sandy, Freudenberg, Florian, Reif, Andreas, Artigas, Maria Soler, Ribases, Marta, Ramos-Quiroga, Josep Antoni, Lesch, Klaus-Peter et al. DOI: 10.1016/j.neuropharm.2019.02.039
PMID: 30804560 Journal: NATURE GENETICS Year: 2019 Reference: Nat Genet. 2019 Mar;51(3):481-493. doi: 10.1038/s41588-018-0321-7. Epub 2019 Feb 25. Impact factor: 25.455 Publication type: Paper in international publication Authors: Wilson, James F, Zhou, Jian, Hui, Jennie, Karrasch, Stefan, Imboden, Medea, Harris, Sarah E, Marten, Jonathan, Enroth, Stefan, Kerr, Shona M, Surakka, Ida et al. DOI: 10.1038/s41588-018-0321-7
PMID: 30646205 Journal: JAMA Network Open Year: 2019 Reference: JAMA Netw Open. 2019 Jan 4;2(1):e186927. doi: 10.1001/jamanetworkopen.2018.6927. Impact factor: 0 Publication type: Paper in international publication Authors: Shrout, Patrick E, Alegria, Margarita, Falgas-Bague, Irene, Collazos, Francisco, Carmona Camacho, Rodrigo, Lapatin Markle, Sheri, Wang, Ye, Baca-Garcia, Enrique, Le Cook, Benjamin, Chavez, Ligia M et al. DOI: 10.1001/jamanetworkopen.2018.6927
PMID: 30613166 Journal: Hepatic medicine : evidence and research Year: 2019 Reference: Hepat Med. 2018 Dec 24;11:1-11. doi: 10.2147/HMER.S187133. eCollection 2019. Impact factor: 0 Publication type: Paper in international publication Authors: Roncero, Carlos, Ryan, Pablo, Littlewood, Richard, Macias, Juan, Ruiz, Juan, Seijo, Pedro, Palma-Alvarez, Raul Felipe, Vega, Pablo et al. DOI: 10.2147/HMER.S187133
PMID: 28256698 Journal: REVISTA DE NEUROLOGIA Year: 2017 Reference: Rev Neurol. 2017 Feb 24;64(s01):S117-S122. Impact factor: 0.743 Publication type: Paper in national publication Authors: Serra-Pla, J F, Pozuelo, M, Richarte, V, Corrales, M, Ibanez, P, Bellina, M, Vidal, R, Calvo, E, Ramos-Quiroga, J A, Casas, M et al. DOI: 10.33588/rn.64S01.2017022
PMID: 27425627 Journal: Revista de calidad asistencial : organo de la Soci Year: 2017 Reference: Rev Calid Asist. 2017 Jan - Feb;32(1):33-39. doi: 10.1016/j.cali.2016.05.004. Epub 2016 Jul 15. Impact factor: 0 Publication type: Paper in national publication Authors: Costa-Requena, G, Cantarell, M C, Moreso, F, Parramon, G, Seron, D et al. DOI: 10.1016/j.cali.2016.05.004
PMID: 27009114 Journal: Current Neuropharmacology Year: 2017 Reference: Curr Neuropharmacol. 2017;15(2):315-323. Impact factor: 3.365 Publication type: Review in international publication Authors: Roncero, Carlos, Abad, Alfonso C, Padilla-Mata, Antonio, Ros-Cucurull, Elena, Barral, Carmen, Casas, Miquel, Grau-Lopez, Lara et al. DOI: 10.2174/1570159X14666160324144912
The doctoral training program of excellence led by the UAB TOUCH MSCA-COFUND, focused on the field of mental health, opens its second call until March 31.
Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.
These results reinforce the need for more individualized attention to address educational needs from an early stage.
